Rita Maria Maffei

Senior Corporate VP Quality Assurance, Regulatory And Clinical Affairs at DiaSorin SpA

Rita Maria Maffei has extensive work experience in quality assurance, regulatory affairs, and clinical affairs in the pharmaceutical industry. Rita Maria started their career at Serono in 1992, where they held various roles including Quality Control Microbiological Supervisor, Quality Assurance GMP Compliance Responsible, and Quality Assurance & Regulatory Compliance Manager. Rita Maria then worked at Merck Serono from 2006 to 2013, serving as Manufacturing Operation Director & Qualified Person and later as Quality Unit Director(QA/QC) & Qualified Person. From 2013 to 2014, they worked at Novartis Vaccines and Diagnostics as the Head of Compliance Italy. Currently, they are at DiaSorin, where they hold the position of Corporate Vice President Quality Assurance, Regulatory and Clinical Affairs, and is responsible for defining the overall direction of the group in respect to quality, ensuring compliance with regulations and standards, and providing leadership in quality assurance and regulatory affairs.

Rita Maria Maffei pursued their education at the Università degli Studi di Bari. From 1984 to 1990, they completed their undergraduate degree in Biologia with a focus on Scienze biologiche. Later, from 1991 to 1995, they obtained a postgraduate degree in Microbiology and Virology from the same institution. Additionally, they received the certification of QP (Qualified Person) in agreement with EMA Regulation & Italian law D.L. n. 178 (2001/83/EC), which they obtained in 2004 through AIFA. Rita Maria'searlier education at Liceo Scientifico Carmine Sylos is not specified.

Location

Vercelli, Italy

Links

Previous companies


Org chart


Teams


Offices

This person is not in any offices


DiaSorin SpA

4 followers

DiaSorin SpA is an Italy-based company engaged in healthcare industry. The Company specializes in provision of developing, producing and commercializing reagent kits for the in vitro diagnostics. The Company develops and manufactures reagents for in vitro diagnostics and produces products for the fields of infectious disease, hepatitis, endocrinology, bone & mineral metabolism, cancer, brain injury, cardiac, therapeutic drug monitoring and autoimmunity. The Company's business activities are divided into two markets. The Immunodiagnostics market develops, produces and markets immunoreagent kits, which are based on three techniques: Chemiluminescence (CLIA), Colorimetry (ELISA) and Radioimmunometry (RIA). The Molecular Diagnostics market supplies end laboratories with an automated result to perform the three steps for the final diagnostic result, including nucleic acids extraction, amplification and diagnosis. It operates through ELISA immunodiagnostic business portfolio.


Industries

Headquarters

Saluggia, Italy

Employees

1,001-5,000

Links